HERTFORDSHIRE, England and
PITTSBURGH, Dec. 20, 2017 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL) today announced that its CEO, Heather Bresch, will present at the 36th Annual
J.P. Morgan Healthcare Conference in San
Francisco, Calif., on Tuesday, Jan.
9, 2018, at 3 p.m. PT (6 p.m.
ET).
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's website at
investor.mylan.com. An archived version also will be available
following the live presentation and can be accessed at the same
location for a limited time.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 7,500 marketed products around the world,
including antiretroviral therapies on which more than 40% of people
being treated for HIV/AIDS globally depend. We market our products
in more than 165 countries and territories. We are one of the
world's largest producers of active pharmaceutical ingredients.
Every member of our more than 35,000-strong workforce is dedicated
to creating better health for a better world, one person at a time.
Learn more at Mylan.com. We routinely post information that may be
important to investors on our website at investor.mylan.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300573820.html
SOURCE Mylan N.V.